TBPH Theravance Biopharma, Inc.: institutional ownership and insider trading
171 funds reported holding $875M of Theravance Biopharma, Inc. in their latest 13F filings; in Q2 2026 funds net sold $44.8M, with 33 new positions and 27 funds selling out; over the last 12 months insiders bought $0 and sold $8.77M on the open market.
Famous investors holding TBPH
- Two Sigma (Two Sigma Investments): $20.8M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $20.2M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $9.14M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.62M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.96M, 0.0% of the portfolio
Largest institutional holders of TBPH
- Madison Avenue Partners, LP — $157M
- Weiss Asset Management LP — $127M
- BlackRock, Inc. (BLK) — $77.6M
- Newtyn Management, LLC — $58.4M
- Irenic Capital Management LP — $46.9M
- VANGUARD GROUP INC — $44.3M
- VANGUARD CAPITAL MANAGEMENT LLC — $30.1M
- STATE STREET CORP (STT, STT-PG) — $22.6M
- TWO SIGMA INVESTMENTS, LP — $20.8M
- D. E. Shaw & Co., Inc. — $20.2M
Recent TBPH insider trades
- Sep 15, 2026: Farnum Rhonda sold 13,314 shares ($227K)
- Jul 7, 2026: Samaha Eli sold 6,964 shares ($119K)
- Jul 1, 2026: Samaha Eli sold 336,697 shares ($5.79M)
- Jun 15, 2026: Farnum Rhonda sold 13,314 shares ($218K)
Members of Congress trading TBPH
- Mar 24, 2025: George Whitesides sold $15.0K–$50.0K
5%+ owners
- Madison Avenue International LP: 17.7% (Schedule 13G/A, filed Aug 14, 2026)
- Newtyn Management, LLC: 6.7% (Schedule 13G/A, filed Aug 14, 2026)